ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,533Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 944

$546K Total Retail Price of All Prescriptions

Rank: 166 out of 944

454 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

10% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 9,232 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
OMEPRAZOLE 436 369 1 4
SIMVASTATIN 359 318 2 1
LEVOTHYROXINE SODIUM 332 308 3 2
FUROSEMIDE 309 290 4 6
LISINOPRIL 284 265 5 3
ATENOLOL 267 256 6 11
METOPROLOL TARTRATE 246 231 7 8
WARFARIN SODIUM 238 151 8 7
HYDROCHLOROTHIAZIDE 226 219 9 9
AMLODIPINE BESYLATE 216 216 10 5
HYDROCODONE-ACETAMINOPHEN 172 129 S3 11 10
METFORMIN HCL 171 134 12 12
POTASSIUM CHLORIDE 170 167 13 15
GABAPENTIN 167 123 14 18
MIRTAZAPINE 157 154 15 35
CITALOPRAM HBR 138 122 16 19
DIGOXIN 133 98 17 39
POLYETHYLENE GLYCOL 3350 132 122 18 41
RANITIDINE HCL 132 117 18 42
LOVASTATIN 124 116 20 26
PREDNISONE 121 116 21 32
PRAVASTATIN SODIUM 108 98 22 17
LOSARTAN POTASSIUM 103 103 23 16
TRIAMTERENE-HCTZ 102 102 24 33
TRAZODONE HCL 100 93 25 45
SPIRONOLACTONE-HCTZ 98 93 26 176
GLYBURIDE 94 84 R 27 63
TRAMADOL HCL 89 82 28 21
SYNTHROID 84 83 29 82
CEPHALEXIN 79 78 30 163
FENTANYL 74 66 S2 31 57
OXYCODONE HCL 72 54 S2 32 50
SPIRONOLACTONE 72 56 32 44
OXYCODONE-ACETAMINOPHEN 72 41 S2 32 62
DONEPEZIL HCL 70 67 35 24
ALENDRONATE SODIUM 70 64 35 20
IBUPROFEN 70 63 35 140
FLUTICASONE PROPIONATE 69 56 38 40
ALLOPURINOL 66 62 39 22
ZOLPIDEM TARTRATE 63 48 40 25
IPRATROPIUM-ALBUTEROL 62 58 41 101
ESCITALOPRAM OXALATE 61 58 42 98
CYCLOBENZAPRINE HCL 58 45 R 43 86
DIOVAN 57 53 44 38
NAMENDA 57 51 44 37
FLUOXETINE HCL 56 28 46 48
ATORVASTATIN CALCIUM 53 53 47 13
CLOPIDOGREL 52 51 48 36
DETROL LA 52 49 48 159
HYDRALAZINE HCL 51 43 50 87
OXYBUTYNIN CHLORIDE ER 51 26 50 102
SERTRALINE HCL 51 51 50 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.